Which has the lower trailing P/E, IDXX or UI?

UI has the lower trailing P/E: IDXX trades at 41.02 and UI at 34.68. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, IDXX or UI?

Over the past five years, UI grew revenue faster — IDXX at a 9.24% CAGR versus UI at 12.27%.

Does IDXX or UI pay a bigger dividend?

UI pays a dividend (0.59% yield), while IDXX has no payments in the available dividend history.

Is IDXX or UI more profitable?

UI runs the higher net margin — IDXX at 24.63% versus UI at 30.43%.

How have IDXX and UI total returns compared?

Over the past 10 years, IDXX delivered 19.98% and UI delivered 29.42% annualized total return. Past performance doesn't predict future results.

IDEXX Laboratories, Inc. (IDXX) vs Ubiquiti Inc. (UI)

A side-by-side comparison of IDEXX Laboratories, Inc. and Ubiquiti Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: IDXX is classified in Healthcare; UI is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

IDXX

IDEXX Laboratories, Inc.

$44.93B

$569.54HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Ubiquiti Inc.

$32.36B

$534.72TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — IDXX vs UI

growth of $100 · dividends reinvested · last 15y

IDXX +1490.6%UI +3282.1%UI compounded faster

IDXX UI

IDXX vs UI: by the numbers

•IDXX is the larger company ($44.93B vs $32.36B market cap).
•UI trades at the lower trailing earnings multiple (34.68 vs 41.02 P/E), one valuation lens rather than an overall verdict.
•UI converts more revenue to profit (30.43% vs 24.63% net margin).
•UI grew revenue faster over the past five years (12.27% vs 9.24% CAGR).
•UI pays a dividend (0.59% yield), while IDXX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	IDXX	UI
P/E ratio	41.02	34.68
Forward P/E	37.97	35.38
P/S ratio	10.09	10.56
P/B ratio	28.84	27.19
PEG ratio	2.31	0.34
EV / EBITDA	29.44	28.78
FCF yield	2.41%	2.29%

Profitability

Metric	IDXX	UI
Gross margin	62.05%	46.02%
Operating margin	31.63%	35.75%
Net margin	24.63%	30.43%
ROE	70.38%	78.37%
ROIC	40.27%	72.62%

Dividends

Metric	IDXX	UI
Dividend yield	N/A	0.59%
Payout ratio	N/A	27.19%

Growth (annualized)

Metric	IDXX	UI
Revenue CAGR (5Y)	9.24%	12.27%
EPS CAGR (5Y)	14.07%	15.17%
FCF CAGR (5Y)	10.13%	6.21%
Total return CAGR (5Y)	-3.70%	13.32%

Frequently asked

Which has the lower trailing P/E, IDXX or UI?: UI has the lower trailing P/E: IDXX trades at 41.02 and UI at 34.68. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, IDXX or UI?: Over the past five years, UI grew revenue faster — IDXX at a 9.24% CAGR versus UI at 12.27%.
Does IDXX or UI pay a bigger dividend?: UI pays a dividend (0.59% yield), while IDXX has no payments in the available dividend history.
Is IDXX or UI more profitable?: UI runs the higher net margin — IDXX at 24.63% versus UI at 30.43%.
How have IDXX and UI total returns compared?: Over the past 10 years, IDXX delivered 19.98% and UI delivered 29.42% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IDXX analysis Full UI analysis Interactive comparison tool

Dig into the metrics

IDEXX Laboratories P/E ratio Ubiquiti P/E ratio IDEXX Laboratories dividend yield Ubiquiti dividend yield IDEXX Laboratories ROE Ubiquiti ROE IDEXX Laboratories operating margin Ubiquiti operating margin IDEXX Laboratories revenue growth Ubiquiti revenue growth IDEXX Laboratories free cash flow Ubiquiti free cash flow

IDEXX Laboratories & Ubiquiti appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.